Dr. Tyson Lahti, DO

NPI: 1477814846
Total Payments
$779.89
2024 Payments
$123.38
Companies
17
Transactions
41
Medicare Patients
349
Medicare Billing
$3,671

Payment Breakdown by Category

Food & Beverage$722.89 (92.7%)
Other$57.00 (7.3%)

Payments by Nature

Nature of Payment Amount Transactions Share
Food and Beverage $722.89 40 92.7%
Debt forgiveness $57.00 1 7.3%

Top Paying Companies

Company Total Records Latest Year
Supernus Pharmaceuticals, Inc. $196.01 10 $0 (2024)
Otsuka America Pharmaceutical, Inc. $130.38 7 $0 (2020)
Welch Allyn $57.00 1 $0 (2021)
Lilly USA, LLC $54.08 3 $0 (2024)
Novo Nordisk Inc $53.44 3 $0 (2023)
ABBVIE INC. $47.18 3 $0 (2024)
Amgen Inc. $40.14 2 $0 (2020)
Neurocrine Biosciences, Inc. $38.17 2 $0 (2023)
Boehringer Ingelheim Pharmaceuticals, Inc. $25.41 1 $0 (2022)
Lundbeck LLC $23.55 1 $0 (2023)

Payment History by Year

Year Amount Transactions Top Company
2024 $123.38 6 Supernus Pharmaceuticals, Inc. ($88.77)
2023 $186.08 10 Supernus Pharmaceuticals, Inc. ($70.65)
2022 $94.93 5 Boehringer Ingelheim Pharmaceuticals, Inc. ($25.41)
2021 $69.25 2 Welch Allyn ($57.00)
2020 $56.25 3 Otsuka America Pharmaceutical, Inc. ($40.59)
2019 $51.85 3 Amgen Inc. ($24.48)
2018 $88.47 6 Otsuka America Pharmaceutical, Inc. ($29.33)
2017 $109.68 6 Otsuka America Pharmaceutical, Inc. ($60.46)

All Payment Transactions

41 individual payment records from CMS Open Payments — Page 1 of 2

Date Company Product Nature Form Amount Type
04/02/2024 Supernus Pharmaceuticals, Inc. Qelbree (Drug) Food and Beverage In-kind items and services $17.00 General
Category: VILOXAZINE HYDROCHLORIDE
04/02/2024 Supernus Pharmaceuticals, Inc. Qelbree (Drug) Food and Beverage In-kind items and services $14.00 General
Category: VILOXAZINE HYDROCHLORIDE
02/07/2024 Supernus Pharmaceuticals, Inc. Qelbree (Drug) Food and Beverage In-kind items and services $17.51 General
Category: VILOXAZINE HYDROCHLORIDE
02/07/2024 ABBVIE INC. VRAYLAR (Drug) Food and Beverage In-kind items and services $13.15 General
Category: NEUROSCIENCE
01/24/2024 Supernus Pharmaceuticals, Inc. Qelbree (Drug) Food and Beverage In-kind items and services $40.26 General
Category: VILOXAZINE HYDROCHLORIDE
01/10/2024 Lilly USA, LLC MOUNJARO (Drug) Food and Beverage In-kind items and services $21.46 General
Category: Diabetes
12/05/2023 Supernus Pharmaceuticals, Inc. QELBREE (Drug) Food and Beverage Cash or cash equivalent $23.45 General
Category: PSYCHOLOGY
11/08/2023 Supernus Pharmaceuticals, Inc. QELBREE (Drug) Food and Beverage Cash or cash equivalent $15.63 General
Category: PSYCHOLOGY
10/18/2023 Supernus Pharmaceuticals, Inc. QELBREE (Drug) Food and Beverage Cash or cash equivalent $15.09 General
Category: PSYCHOLOGY
10/13/2023 Lundbeck LLC REXULTI (Drug) Food and Beverage Cash or cash equivalent $23.55 General
Category: PSYCHIATRY
09/21/2023 Supernus Pharmaceuticals, Inc. QELBREE (Drug) Food and Beverage Cash or cash equivalent $16.48 General
Category: PSYCHOLOGY
09/14/2023 Neurocrine Biosciences, Inc. INGREZZA (Drug) Food and Beverage In-kind items and services $17.25 General
Category: Neuropsychiatry
06/08/2023 Novo Nordisk Inc Rybelsus (Drug), Ozempic Food and Beverage In-kind items and services $20.54 General
Category: Diabetes
04/14/2023 ABBVIE INC. VRAYLAR (Drug) Food and Beverage In-kind items and services $14.81 General
Category: NEUROSCIENCE
03/09/2023 Novo Nordisk Inc Saxenda (Drug), Wegovy Food and Beverage In-kind items and services $18.36 General
Category: Obesity
02/09/2023 Neurocrine Biosciences, Inc. INGREZZA (Drug) Food and Beverage In-kind items and services $20.92 General
Category: Neuropsychiatry
12/07/2022 Lilly USA, LLC MOUNJARO (Drug) Food and Beverage In-kind items and services $20.37 General
Category: Diabetes
10/13/2022 ABBVIE INC. VRAYLAR (Drug) Food and Beverage In-kind items and services $19.22 General
Category: NEUROSCIENCE
09/08/2022 Supernus Pharmaceuticals, Inc. QELBREE (Drug) Food and Beverage Cash or cash equivalent $15.39 General
Category: PSYCHOLOGY
05/12/2022 Novo Nordisk Inc Ozempic (Drug), Rybelsus Food and Beverage In-kind items and services $14.54 General
Category: Diabetes
03/10/2022 Boehringer Ingelheim Pharmaceuticals, Inc. STIOLTO RESPIMAT (Drug), SPIRIVA RESPIMAT Food and Beverage In-kind items and services $25.41 General
Category: RESPIRATORY
11/23/2021 Welch Allyn None (Device) Debt forgiveness Cash or cash equivalent $57.00 General
Category: Not Applicable
10/13/2021 Lilly USA, LLC TRULICITY (Drug), JARDIANCE Food and Beverage In-kind items and services $12.25 General
Category: Diabetes
10/08/2020 Otsuka America Pharmaceutical, Inc. REXULTI (Drug) Food and Beverage In-kind items and services $22.13 General
Category: PSYCHIATRY
09/10/2020 Amgen Inc. Aimovig (Biological), Repatha Food and Beverage In-kind items and services $15.66 General
Category: Neuroscience

Medicare Billing by Year

Year Procedures Beneficiaries Services Submitted Medicare Paid
2023 3 69 108 $2,433 $719.91
2022 3 78 121 $2,651 $796.04
2021 3 82 102 $2,962 $944.76
2020 5 120 144 $4,012 $1,210
Total Patients
349
Total Services
475
Medicare Billing
$3,671
Procedure Codes
14

All Medicare Procedures & Services

14 procedure records from CMS Medicare Utilization

HCPCS Description Setting Year Patients Services Charges Medicare Paid Ratio
83036 Hemoglobin a1c level Office 2023 35 58 $1,434 $552.16 38.5%
82947 Blood glucose (sugar) level Office 2023 23 35 $793.00 $134.75 17.0%
81003 Automated urinalysis test Office 2023 11 15 $206.00 $33.00 16.0%
83036 Hemoglobin a1c level Office 2022 39 62 $1,488 $592.76 39.8%
82947 Blood glucose (sugar) level Office 2022 28 44 $968.00 $170.12 17.6%
81003 Automated urinalysis test Office 2022 11 15 $195.00 $33.16 17.0%
83036 Hemoglobin a1c level Office 2021 33 45 $1,080 $436.95 40.5%
80061 Blood test, lipids (cholesterol and triglycerides) Office 2021 25 30 $1,306 $401.70 30.8%
82947 Blood glucose (sugar) level Office 2021 24 27 $576.00 $106.11 18.4%
80061 Blood test, lipids (cholesterol and triglycerides) Office 2020 36 42 $1,722 $558.33 32.4%
83036 Hemoglobin a1c level Office 2020 38 47 $1,128 $454.28 40.3%
82947 Blood glucose (sugar) level Office 2020 22 25 $500.00 $98.09 19.6%
G0071 Payment for communication technology-based services for 5 minutes or more of a virtual (non-face-to-face) communication between an rural health clinic (rhc) or federally qualified health center (fqhc) practitioner and rhc or fqhc patient, or 5 minutes or m Office 2020 12 14 $470.00 $63.60 13.5%
81003 Automated urinalysis test Office 2020 12 16 $192.00 $35.60 18.5%

About Dr. Tyson Lahti, DO

Dr. Tyson Lahti, DO is a Pediatrics healthcare provider based in Muskegon, Michigan. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/01/2012. The National Provider Identifier (NPI) number assigned to this provider is 1477814846.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Tyson Lahti, DO has received a total of $779.89 in payments from pharmaceutical and medical device companies, with $123.38 received in 2024. These payments were reported across 41 transactions from 17 companies. The most common payment nature is "Food and Beverage" ($722.89).

As a Medicare-enrolled provider, Lahti has provided services to 349 Medicare beneficiaries, totaling 475 services with total Medicare billing of $3,671. Data is available for 4 years (2020–2023), covering 14 distinct procedure/service records.

Practice Information

  • Specialty Pediatrics
  • Other Specialties Internal Medicine
  • Location Muskegon, MI
  • Active Since 06/01/2012
  • Last Updated 04/01/2024
  • Taxonomy Code 208000000X
  • Entity Type Individual
  • NPI Number 1477814846

Products in Payments

  • REXULTI (Drug) $153.93
  • Qelbree (Drug) $88.77
  • QELBREE (Drug) $86.04
  • None (Device) $57.00
  • VRAYLAR (Drug) $47.18
  • MOUNJARO (Drug) $41.83
  • Aimovig (Biological) $40.14
  • INGREZZA (Drug) $38.17
  • STIOLTO RESPIMAT (Drug) $25.41
  • BEXSERO (Biological) $21.55
  • TROKENDI XR (Drug) $21.20
  • Rybelsus (Drug) $20.54
  • Saxenda (Drug) $18.36
  • NEXPLANON (Drug) $15.81
  • Fanapt (Drug) $15.34
  • VYVANSE (Drug) $14.58
  • Ozempic (Drug) $14.54
  • Adzenys XR-ODT (Drug) $12.66
  • TRULICITY (Drug) $12.25
  • LYRICA (Drug) $12.03

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Pediatrics Doctors in Muskegon